Competition With Striatal [11C]ORM-13070 Binding by Atipamezole and Endogenous Noradrenaline
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to validate [11C]ORM-13070 as an alpha2C-adrenoceptor imaging
agent for human positron emission tomography (PET) studies of brain alpha2C-adrenoceptor
occupancy.